Issued on behalf of GT Biopharma, Inc. Equity Insider News Commentary – The oncology sector's pivot toward platform-based precision therapies has signaled smart money abandoning single-asset risk for companies engineering multiple drugs from validated mechanisms[1]. Antibody-drug conjugate pipelines expanding past 200 clinical candidates demonstrate how platform technologies enable rapid target-swapping while preserving core therapeutic advantages, […]

The following issues have been halted by CIRO Company: Bear Creek Mining Corporation TSX-Venture Symbol: BCM All Issues: Yes Reason: Pending News Halt Time (ET):7:49 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with $599 Million in Revenue Over Past Four Quarters Provides Opportunity to Expand Access to Galafold and Pombiliti + Opfolda to Patients in New Markets Across BioMarin's Global Footprint; Pending U.S. Galafold

Eighth securitization of Achieve HELOCs is first to be rated by S&P Global Achieve, the leader in digital personal finance, announces the Dec. 16 close of a $271.2 million, AAA-rated securitization backed by newly originated home equity lines of credit (HELOCs). https://mma.prnewswire.com/media/1905050/Achieve_Logo.jpg The securitization, ACHM Trust 2025-HE3, includes six classes of rated, mortgage-backed notes and

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, announced the termination of its binding commitment to acquire The Cannabist Company's Virginia assets (the “Virginia Assets”). A competing bid valued the Virginia Assets at $130 million plus the assumption of a $30 million lease liability.

Issued on behalf of GT Biopharma, Inc. USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for second-line blood cancer treatment marks the departure from traditional chemotherapy that oncologists have been anticipating for decades[1]. Engineered cell therapies and bispecific antibodies are now achieving response rates exceeding

New findings uncover a rapid molecular switch that rewires plant growth under cold stress, opening pathways to climate-resilient crops A research team from Korea have uncovered how plants rapidly activate a hidden genetic “switch” helping them survive in cold environments. They demonstrate that low temperatures induce a rewiring of a hormone signaling pathway, triggering the

TNLMediagene (Nasdaq: TNMG) (the “Company”), a Tokyo-based next-generation digital media and data group in Asia, today issued a letter to shareholdersfrom Joey Chung, Co-Founder and CEO, and Motoko Imada, Co-Founder and President of TNL Mediagene, discussing key recent positive and notable developments, milestones and achievements of the Company year-to-date in 2025 and plans for the

Today Conagra Brands, Inc. (NYSE: CAG) reported results for the second quarter of fiscal year 2026, which ended on November 23, 2025. All comparisons are against the prior year fiscal period, unless otherwise noted. https://mma.prnewswire.com/media/479094/CB_CMYK_Texture_Logo.jpg Highlights — Reported net sales decreased 6.8%; organic net sales decreased 3.0%. — Reported operating margin was (20.1)%; adjusted operating

C$ unless otherwise stated Manulife Investments today announced the 2025 annual reinvested distribution estimates for Manulife Exchange Traded Funds (ETFs). These annual reinvested distributions generally represent realized capital gains within the ETFs. Please note that these are estimated capital gains amounts only as of December 15, 2025, and reflect forward-looking information which may cause these